0001827506-24-000055.txt : 20240607 0001827506-24-000055.hdr.sgml : 20240607 20240607160311 ACCESSION NUMBER: 0001827506-24-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCDADE MARK CENTRAL INDEX KEY: 0001242126 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 241029212 MAIL ADDRESS: STREET 1: C/O PROTINE DESIGN LAB STREET 2: 7442 NORTH MARCER WAY CITY: MERCER ISLAND STATE: WA ZIP: 98040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tourmaline Bio, Inc. CENTRAL INDEX KEY: 0001827506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 WEST 24TH STREET STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-481-9832 MAIL ADDRESS: STREET 1: 27 WEST 24TH STREET STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Talaris Therapeutics, Inc. DATE OF NAME CHANGE: 20201007 4 1 wk-form4_1717790581.xml FORM 4 X0508 4 2024-06-05 0 0001827506 Tourmaline Bio, Inc. TRML 0001242126 MCDADE MARK C/O QIMING U.S. VENTURES MANAGEMENT, LLC 11100 NE 8TH ST., SUITE 200 BELLEVUE WA 98004 1 0 0 0 0 Stock Option (Right to Buy) 13.91 2024-06-05 4 A 0 10000 0 A 2034-06-04 Common Stock 10000 10000 D 100% of the shares subject to the option vest on the earlier of the anniversary of the Transaction Date or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on such vesting date. /s/ Brad Middlekauff, Attorney-in-Fact 2024-06-07